Artwork
iconShare
 
Manage episode 493125497 series 3552382
Content provided by Michael Pietrack. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pietrack or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

On this episode of The Pharmaverse Podcast, Art Krieg, the President of Zola Therapeutics, tells Michael that vision, endurance, resilience, and a whole lot of grit are needed to run a biotech.
Krieg has faced the rugged terrain and uphill climbs that come with building science-based companies. But just like a marathoner, he’s never stopped putting one foot in front of the other.
🎧 In this episode, Art and Michael discuss:
✅ The parallels between biotech leadership and long-distance running
✅ Lessons learned from exits, IPOs, and immuno-oncology breakthroughs
✅ Why perseverance and pacing are more important than ever in today’s market
📲 Follow The Pharmaverse Podcast on LinkedIn, X, YouTube, or wherever you get your podcasts.
#pharmaversepodcast
𝐂𝐎𝐍𝐍𝐄𝐂𝐓 𝐖𝐈𝐓𝐇 𝐔𝐒:
▶ Website: [https://www.kbic.com/recruiting/pharm...]
▶ LinkedIn: [ https://www.linkedin.com/in/michaelpietrack/ ]
▶ Website: [ https://linktr.ee/pharmaverse ]
▶ Check out his podcast:[ https://www.linkedin.com/company/99101554 ]
▶ Have you seen all of our playlists? [https://www.youtube.com/@ThePharmaversePodcast/playlists ]
▶ Also, join the private LinkedIn Job Board: MSL Job Board

  continue reading

37 episodes